8 research outputs found

    Physiological Responses to Different Diets in Intervention Group, including drop-outs (Intent-to-treat) (N = 41).

    No full text
    a<p>BP, blood pressure; CRP, C-reactive protein; HOMA-IR, Homeostatic model assessment-insulin resistance; OGTT, oral glucose tolerance test; PAI-1, plasminogen activator inhibitor-1; % B, endothelium-mediated dilation; % N, non-endothelium-mediated dilation; IL, interleukin; TAD, traditional Asian diet; TNF-α, tumor necrosis factor-alpha; TWD, typical Western diet.</p>b<p>P-value of the changes observed before and after 8 weeks of TAD (Visit 3-Visit 2).</p>c<p>P-value of the changes observed before and after 8 weeks of TWD (Visit 4-Visit 3).</p>d<p>P-value of the Visit 4-Visit 3 and Visit 3-Visit 2.</p><p>Physiological Responses to Different Diets in Intervention Group, including drop-outs (Intent-to-treat) (N = 41).</p

    Physiological Responses to Different Diets among Asian Americans and Caucasian Americans in Intervention Group, including drop-outs (Intent-to-treat).

    No full text
    a<p>BP, blood pressure; CRP, C-reactive protein; HOMA-IR, Homeostatic model assessment-insulin resistance; OGTT, oral glucose tolerance test; PAI-1, plasminogen activator inhibitor-1; % B, endothelium-mediated dilation; % N, non-endothelium-mediated dilation; IL, interleukin; TAD, traditional Asian diet; TNF-α, tumor necrosis factor-alpha; TWD, typical Western diet.</p>b<p>P-value of the changes observed before and after 8 weeks of TAD (Visit 3-Visit 2).</p>c<p>P-value of the changes observed before and after 8 weeks of TWD (Visit 4-Visit 3).</p>d<p>P-value of the Visit 4-Visit 3 and Visit 3-Visit 2.</p><p>Physiological Responses to Different Diets among Asian Americans and Caucasian Americans in Intervention Group, including drop-outs (Intent-to-treat).</p

    Baseline Profile for all participants enrolled Asian Americans vs Caucasian Americans (N = 50).

    No full text
    a<p>BP, blood pressure; CRP, C-reactive protein; HbA<sub>1c</sub>, glycosylated hemoglobin; HOMA-IR, Homeostatic model assessment-insulin resistance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; OGTT, oral glucose tolerance test; PAI-1, plasminogen activator inhibitor-1; % B, endothelium-mediated dilation; % N, non-endothelium-mediated dilation; IL, interleukin; TNF-α, tumor necrosis factor-alpha.</p><p>Baseline Profile for all participants enrolled Asian Americans vs Caucasian Americans (N = 50).</p

    Gross and Adjusted Correlations with GDR.

    No full text
    <p>Data are presented as Pearson correlation coefficient (R), and corresponding p value. Variables presented: BMI, C-Reactive Protein (CRP), Adipocyte Fatty Acid-Binding Protein (A-FABP), Retinol Binding Protein-4 (RBP-4), Total Body Fat (TBF%) by DEXA, and Truncal Fat percentage (TF%). Type 1 diabetes group (Type 1), Type 2 diabetes group (Type 2). Adjusted correlations with GDR by age, gender and BMI.</p

    Relationship between glucose infusion rate (GDR) and various biomarkers for insulin resistance.

    No full text
    <p>Relationship between GDR and Adiponectin, Free fatty acid (FFA), Waist circumference, A-FABP, C-reactive protein (CRP), Total Body Fat (TBF) by DEXA, BMI, and Retinol Binding Protein-4 (RBP-4). Circles = Type 1 group; Squares = Type 2 diabetes group; Triangles = Control group.</p

    Baseline characteristics, separated by group.

    No full text
    <p>Data are means ± SD or n (%). ANOVA performed between all 3 groups: Type 1 Diabetes, Type 2 Diabetes, and Controls.</p><p>*Auto-antibody positivity to islet cell antigens was determined by serum concentration>0.1 nU/ml for GAD & IA2, expressed as number of individuals (percent positive).</p>‡<p>Chi-Square tests were performed in these categories.</p
    corecore